A revolutionary platform biotech company, Grove Biopharma operates at the intersection of materials science and medicinal chemistry. Based on the work from the lab of Northwestern University Professor Nathan Gianneschi, Grove focuses on the discovery and development of a new class of biotherapeutics to treat significant unmet medical needs in chronic inflammatory and neurodegenerative diseases.